Goldman Sachs’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-254
Closed -$4.62K 6363
2024
Q3
$4.62K Sell
254
-12,248
-98% -$214K ﹤0.01% 5734
2024
Q2
$302K Buy
12,502
+10,394
+493% +$323K ﹤0.01% 5106
2024
Q1
$91.9K Sell
2,108
-9,263
-81% -$384K ﹤0.01% 5259
2023
Q4
$464K Buy
11,371
+425
+4% +$23.1K ﹤0.01% 4798
2023
Q3
$906K Sell
10,946
-721
-6% -$65.4K ﹤0.01% 4333
2023
Q2
$1.11M Sell
11,667
-152
-1% -$19.5K ﹤0.01% 4278
2023
Q1
$1.63M Buy
11,819
+273
+2% +$25K ﹤0.01% 4022
2022
Q4
$827K Sell
11,546
-725
-6% -$68.6K ﹤0.01% 4550
2022
Q3
$1.45M Sell
12,271
-62
-0.5% -$11K ﹤0.01% 4239
2022
Q2
$2.25M Sell
12,333
-12,944
-51% -$2.35M ﹤0.01% 3943
2022
Q1
$5.92M Sell
25,277
-3,536
-12% -$714K ﹤0.01% 3198
2021
Q4
$9.82M Sell
28,813
-10,078
-26% -$5.55M ﹤0.01% 2789
2021
Q3
$25.4M Buy
38,891
+15,892
+69% +$11.7M 0.01% 1838
2021
Q2
$23M Buy
22,999
+4,687
+26% +$4.67M 0.01% 1924
2021
Q1
$27.7M Buy
18,312
+13,695
+297% +$22.2M 0.01% 1660
2020
Q4
$4.34M Buy
+4,617
New +$2.48M ﹤0.01% 3112

Other funds holding DNMR

Goldman Sachs's DNMR Position: Q4 2024 in Review

Goldman Sachs sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 254 shares — an estimated $4.62K sold.

Goldman Sachs first reported a position in DNMR in Q4 2020 and held it in 16 quarters. The position peaked at $27.7M in Q1 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Goldman Sachs reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 254 Danimer Scientific, Inc. shares in Q4 2024, an estimated $4.62K.
  • Goldman Sachs first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 16 quarters.
  • Goldman Sachs's Danimer Scientific, Inc. position peaked at $27.7M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.